dr. bekaii saab on the role of immunotherapy in crc
Published 7 years ago • 74 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
3:29
tanios bekaii-saab md, facp, considers the emerging role of immunotherapy in advanced crc treatment
-
0:46
dr. bekaii saab on immunotherapeutic options in crc beyond pd-1/pd-l1
-
1:49
dr. bekaii-saab on immunotherapy in colorectal cancer
-
1:28
dr. bekaii-saab on the response rate of pembrolizumab in msi-h crc
-
0:57
dr. bekaii-saab on the importance of the redos study in mcrc
-
1:33
dr. bekaii saab on the expansion of treatment options in colorectal cancer
-
1:55
dr. bekaii-saab on challenges with precision medicine in crc
-
1:49
dr. bekaii-saab on resistance to targeted therapy in crc
-
2:06
dr. bekaii-saab on the impact of the beacon crc study in braf-mutated crc
-
0:58
dr. morris on the role of immunotherapy in metastatic crc
-
1:13
dr. bekaii-saab on the addition of atezolizumab to capecitabine/bevacizumab in mss mcrc
-
2:26
dr. bekaii-saab on the impact of regorafenib in crc
-
1:20
dr. saab on immunotherapy in msi-h gi malignancies
-
3:47
dr bekaii-saab on the future of treatment for patients with gi cancer
-
3:27
crc: emerging immunotherapy strategies in mss tumors
-
1:26
dr. bekaii-saab on immunotherapy and viral therapy for pancreatic cancer
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:01
dr. bekaii-saab on safety profile of tucatinib/trastuzumab in her2 amplified mcrc
-
1:45
dr. bekaii-saab on moving metastatic treatment strategies to the adjuvant setting in crc